NO902491L - Proteiner, vaksiner og nukleinsyrer. - Google Patents
Proteiner, vaksiner og nukleinsyrer.Info
- Publication number
- NO902491L NO902491L NO90902491A NO902491A NO902491L NO 902491 L NO902491 L NO 902491L NO 90902491 A NO90902491 A NO 90902491A NO 902491 A NO902491 A NO 902491A NO 902491 L NO902491 L NO 902491L
- Authority
- NO
- Norway
- Prior art keywords
- proteins
- vaccines
- nucleic acids
- protein
- production
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 101000633984 Homo sapiens Influenza virus NS1A-binding protein Proteins 0.000 abstract 3
- 102100029241 Influenza virus NS1A-binding protein Human genes 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 206010014599 encephalitis Diseases 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP89305708 | 1989-06-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO902491D0 NO902491D0 (no) | 1990-06-05 |
NO902491L true NO902491L (no) | 1990-12-07 |
Family
ID=8202711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO90902491A NO902491L (no) | 1989-06-06 | 1990-06-05 | Proteiner, vaksiner og nukleinsyrer. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0402116B1 (hu) |
JP (1) | JPH03151878A (hu) |
AT (1) | ATE143373T1 (hu) |
CA (1) | CA2018332A1 (hu) |
CZ (1) | CZ277921B6 (hu) |
DD (1) | DD297997A5 (hu) |
DE (1) | DE69028658T2 (hu) |
FI (1) | FI902814A0 (hu) |
HU (1) | HUT54306A (hu) |
NO (1) | NO902491L (hu) |
SK (1) | SK277781B6 (hu) |
YU (1) | YU109590A (hu) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4224402A1 (de) * | 1992-07-21 | 1994-01-27 | Schering Ag | Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung |
FR2794865B1 (fr) | 1999-06-09 | 2003-04-18 | Pasteur Institut | Methode de detection precoce des flavivirus et ses applications |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2074422T3 (es) * | 1987-03-20 | 1995-09-16 | Immuno Ag | Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso. |
IL91304A0 (en) * | 1988-08-20 | 1990-03-19 | Us Health | Recombinant vaccinia virus for prevention of disease caused by flavivirus |
-
1990
- 1990-06-05 HU HU903490A patent/HUT54306A/hu unknown
- 1990-06-05 CA CA002018332A patent/CA2018332A1/en not_active Abandoned
- 1990-06-05 FI FI902814A patent/FI902814A0/fi not_active Application Discontinuation
- 1990-06-05 DD DD90341327A patent/DD297997A5/de not_active IP Right Cessation
- 1990-06-05 YU YU109590A patent/YU109590A/sh unknown
- 1990-06-05 NO NO90902491A patent/NO902491L/no unknown
- 1990-06-06 AT AT90306154T patent/ATE143373T1/de not_active IP Right Cessation
- 1990-06-06 DE DE69028658T patent/DE69028658T2/de not_active Expired - Fee Related
- 1990-06-06 EP EP90306154A patent/EP0402116B1/en not_active Expired - Lifetime
- 1990-06-06 CZ CS902806A patent/CZ277921B6/cs unknown
- 1990-06-06 JP JP2146403A patent/JPH03151878A/ja active Pending
- 1990-06-06 SK SK2806-90A patent/SK277781B6/sk unknown
Also Published As
Publication number | Publication date |
---|---|
HU903490D0 (en) | 1990-10-28 |
DD297997A5 (de) | 1992-01-30 |
EP0402116B1 (en) | 1996-09-25 |
DE69028658T2 (de) | 1997-03-06 |
CZ277921B6 (en) | 1993-06-16 |
DE69028658D1 (de) | 1996-10-31 |
SK277781B6 (en) | 1995-01-05 |
EP0402116A1 (en) | 1990-12-12 |
CS9002806A2 (en) | 1991-11-12 |
HUT54306A (en) | 1991-02-28 |
ATE143373T1 (de) | 1996-10-15 |
CA2018332A1 (en) | 1990-12-06 |
NO902491D0 (no) | 1990-06-05 |
FI902814A0 (fi) | 1990-06-05 |
YU109590A (sh) | 1992-07-20 |
JPH03151878A (ja) | 1991-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK84194A (da) | Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn | |
ES2013346A6 (es) | Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles. | |
ATE373010T1 (de) | Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen | |
HUP0002176A2 (hu) | Vakcinákban vagy diagnosztikai vizsgálatokban alkalmazható PRRSV-peptidszekvenciákat azonosító PRRSV-antigénhelyek | |
DK0754704T3 (da) | Syntetiske antigener til påvisning af antistoffer mod hepatitis c-virus | |
EP0075395A3 (en) | Products displaying the antigenicity of hepatitis b virus e antigens and methods of producing those antigens | |
ES553758A0 (es) | Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia. | |
DK11187D0 (da) | Dna-sekvenser der koder for proteiner med husi-type i inhibitorers biologiske aktivitet, biotekniske fremgangsmaader til fremstilling af proteinerne o g farmaceutiske praeparater der indeholder dem | |
ES2054769T3 (es) | Polipeptidos hiv-2 recombinantes. | |
NO902491L (no) | Proteiner, vaksiner og nukleinsyrer. | |
GB1461188A (en) | Live influenza virus vaccines and preparation thereof | |
DK0495907T3 (da) | cDNA-fragment, som koder for alfa-interferon-receptorgenet, og fremgangsmåde til fremstilling af et tilsvarende protein | |
WO1990012807A3 (en) | Purified, highly specific antibodies against gene products including retinoblastoma and method | |
ROLLAG et al. | Effect of beta‐interferon on in vitro spreading of mouse peritoneal macrophages | |
DK589586A (da) | Ekspression og diagnostisk anvendelse af gag-kodede peptider, der er immunologisk reaktive med antistoffer til lav. | |
DD129805A1 (de) | Verfahren zur herstellung von viruslebendimpfstoffen,insbesondere aujeszky-lebendimpfstoff | |
EP0513371A4 (en) | Human parainfluenza virus type 4a fusion protein and gene which codes for the same | |
DE69021879D1 (de) | Verfahren zur herstellung von impfstoffen gegen rna-virus. | |
HUP9900766A2 (hu) | Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez | |
TH4148A (th) | Dna ชนิดใหม่และโพลิเพนไทด์ | |
TH9629EX (th) | โพรเทเอส, รีเวอร์ส แทรนส์คริพเทส และเอนโดนิวคลี เอสของ ของเรโทรไวรัส และวิธีการสำหรับผลิตเอนไซม์เหล่า นี้ | |
FI934079A (fi) | Menetelmä fuusioproteiinin valmistamiseksi |